Graded Exposure Therapy for Concussion

Q: Is it possible to enlist in this clinical research?

<p>For this trial, 220 individu<a href="https://www.withpower.com/clinical-trials/als">als</a> aged 18-69 who have sustained a <a href="https://www.withpower.com/clinical-trials/traumatic-brain-injury">traumatic brain injury</a> in the past 12 months must be enrolled. Selected patients should also possess <a href="https://www.withpower.com/clinical-trials/flu">flu</a>ency in English, access to internet enabled technology and present with 3 or more moderate-severe symptoms on the Rivermead Postconcussion Symptom Questionnaire.</p>

N/A

Recruiting

Led By Noah Silverberg, PhD

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Sustained a concussion according to the World Health Organization Neurotrauma Task Force definition between 1 and 12 months ago;

3 or more moderate-severe symptoms on the Rivermead Postconcussion Symptom Questionnaire.

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up3 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will assess whether graded exposure therapy is effective in reducing fear avoidance behavior in people with concussion.

Eligible Conditions

Concussion

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You had a mild brain injury (concussion) between 1 to 12 months ago according to the World Health Organization's definition.

Select...

You have at least three moderate to severe symptoms as reported on the Rivermead Postconcussion Symptom Questionnaire.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rivermead Post Concussion Symptoms Questionnaire (RPQ): Change

Secondary outcome measures

World Health Organization Disability Assessment Schedule (WHODAS) 2.0 12-item: interviewer version: Change.

Other outcome measures

Fear Avoidance Behaviour after Traumatic Brain Injury Questionnaire (FAB-TBI): Change

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Arm 1: Graded Exposure TherapyExperimental Treatment1 Intervention

Group II: Arm 2: Prescribed Aerobic ExerciseActive Control1 Intervention

Group III: Arm 3: Enhanced usual careActive Control1 Intervention

0 / 2Eligibility criteria met

Find a site

Who is running the clinical trial?

University of British ColumbiaLead Sponsor

1,371 Previous Clinical Trials

1,439,969 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,297 Previous Clinical Trials

25,481,585 Total Patients Enrolled

Noah Silverberg, PhDPrincipal Investigator

University of British Columbia

5 Previous Clinical Trials

284 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are participating in this research protocol?

"This medical trial needs 220 eligible patients to join. They can register at the Sunnybrooke Traumatic Brain Injury Clinic in Langley, BC or with Fraser Health Acquired Brain Injury and Concussion Services in Calgary, AB."

Answered by AI

Is it possible to enlist in this clinical research?

"For this trial, 220 individuals aged 18-69 who have sustained a traumatic brain injury in the past 12 months must be enrolled. Selected patients should also possess fluency in English, access to internet enabled technology and present with 3 or more moderate-severe symptoms on the Rivermead Postconcussion Symptom Questionnaire."

Answered by AI

What is the current count of participating healthcare facilities in this experiment?

"Currently, 6 different medical centres are enrolling participants in this trial. This includes sites based in Langley, Calgary and Vancouver; among other locales. Selecting the facility nearest you is suggested to reduce any commuting challenges for patients who decide to take part."

Answered by AI

Are applications being accepted for participation in this clinical experiment?

"The details found on clinicaltrials.gov suggest that the trial is still recruiting participants, with initial postings made in early June 2022 and recent updates provided at the beginning of August."

Answered by AI